跳到正文
原文
bioRxiv 预印本· Karan, S., Prakash, S., Chentoufi, A. A., Intharachalit, K., Ng, S. X. L., Hwang, J., Maurya, C., BENMOHAMED, L. ·· 2026-10-02AI 评分22

靶向眼部的PPK T细胞免疫疗法在UVB诱导复发的HLA转基因小鼠模型中预防复发性眼部疱疹感染及疾病,并缓解相关认知、行为与社交缺陷

A Tissue-Targeted Immunotherapy Protects Against Recurrent Ocular Herpes Infection and Disease, and Alleviates the Associated Cognitive, Behavioral, and Social Deficits in a 'Humanized' HLA Transgenic Mouse Model of UVB-Induced Reactivation

AI 导读

一种基于HSV-1优势表位的prime/pull/keep(PPK)T细胞免疫疗法,经AAV8载体眼部给药联合CXCL11与IL-2/IL-15,在潜伏感染HLA-A*0201/DRB1小鼠中几乎完全预防UVB诱导的复发性HSV-1眼病并改善生存。

来源:bioRxiv 预印本 · biorxiv.org